Key result
C-reactive protein (CRP) provides additive value to HDL and total cholesterol for predicting future cardiovascular disease events, even in those at low risk based on lipids.
The study demonstrates CRP's predictive value for cardiovascular disease events, suggesting it enhances risk assessment.
n this issue of Circulation, Ridker and colleagues 1 discuss the incremental value of CRP as a predictor of future CVD events.Their conclusion is that CRP is at least additive to HDL and total cholesterol with respect to risk prediction.In fact, there is some evidence that lipids and CRP are better predictors jointly than would be expected by adding up their individual predictive powers.CRP appeared to predict events in those at low risk on the basis of lipids, and CRP-lipid relationships to events were minimally altered by adjustment for other known CVD risk factors.These findings have important implications for CVD risk assessment and risk management.
No takes yet. Share an insight, caveat, or question.
Russell P. Tracy (1998) conducted an editorial in Cardiovascular Disease. C-reactive protein (CRP) was evaluated on Future CVD events. C-reactive protein (CRP) provides additive value to HDL and total cholesterol for predicting future cardiovascular disease events, even in those at low risk based on lipids.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: